Mirion to Present at the 46th Annual Raymond James Institutional Investor Conference
Mirion (
NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the 46th Annual Raymond James Institutional Investor Conference. The presentation will begin at 9:15 a.m. ET on Wednesday, March 5, 2025.
Mirion to Present at Citi’s 2025 Global Industrial Tech and Mobility Conference
Mirion (
NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2025 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation will begin at 2:40 PM ET on Wednesday, February 19, 2025.
Mirion Announces Record Fourth Quarter and Record Full Year 2024 Financial Results; Reaffirms Full Year 2025 Guidance
Mirion (“we” or the “company”) (
NYSEMIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the fourth quarter and full year ended December 31, 2024.
Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024
Mirion (
NYSEMIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results.
Mirion to Detail Financial Targets and Long-term Strategy at Today’s Investor Day
Mirion (“we” or the “company”) (
NYSEMIR), a leading provider of radiation safety solutions supporting advancements in nuclear power and cancer care, will host an Investor Day today, December 3, 2024, at 2:00pm ET. The event will be held at the New York Stock Exchange in New York, NY. In-person attendance requires prior registration. Interested parties may access the livestream of the event, related published materials and a replay of the event by accessing Mirion’s IR website at ir.mirion.com.
Mirion to Present at Goldman Sachs’ Industrials and Materials Conference
Mirion (
NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Goldman Sachs’ Industrials and Materials Conference in New York, NY. The presentation will begin at 10:40 AM ET on Thursday, December 5, 2024.
Mirion Announces Third Quarter 2024 Financial Results and Updates Full Year Guidance
Mirion (“we” or the “company”) (
NYSEMIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the third quarter ended September 30, 2024.
Mirion Technologies Awarded Strategic Contracts for Sizewell C New Nuclear Power Station Project in the UK
Mirion Technologies (
NYSEMIR), a leading provider of advanced radiation safety solutions, today announced that it has been awarded two significant contracts to support the Sizewell C project, a new 3.2-gigawatt power station for Britain. Leveraging EDF expertise and EPR (European Pressurised Reactor) technology, Sizewell C will generate low-carbon electricity sufficient to power approximately 6 million homes. The development, based in East Suffolk, will mirror the design of the Hinkley Point C nuclear power station currently under construction in the Somerset region.
Mirion to Host Investor Day on December 3, 2024
Mirion (
NYSEMIR), a leading provider of radiation safety solutions supporting advancements in nuclear power and cancer care, today announced that it will host an Investor Day on Tuesday, December 3, 2024, beginning at 2:00 p.m. ET. The event will be held at the New York Stock Exchange and webcast live.
Mirion Announces Earnings Release and Conference Call Date for Third Quarter 2024
Mirion (
NYSEMIR) announced today that it will release financial results for third quarter 2024 after market close on Tuesday, October 29, 2024. Following the news release, the company will host a conference call the next day, Wednesday, October 30, 2024, at 11:00 am ET to discuss the results.
Varian Announces Alliance with Sun Nuclear to Elevate and Expand Quality Assurance Offerings
Varian, a Siemens Healthineers company, and Sun Nuclear, a Mirion Medical company (
NYSEMIR), announced an alliance to expand Varian’s comprehensive quality assurance (QA) offerings and interoperability for current and future radiotherapy solutions.
Mirion Announces Second Quarter 2024 Financial Results and Updates Full Year Guidance
Mirion (“we” or the “company”) (
NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the second quarter ended June 30, 2024.
Mirion Announces Earnings Release and Conference Call Date for Second Quarter 2024
Mirion (
NYSEMIR) announced today that it will release financial results for second quarter 2024 after market close on Thursday, August 1, 2024. Following the news release, the company will host a conference call the next day, Friday, August 2, 2024, at 11:00 am ET to discuss the results.
Mirion Announces Updated Time of Presentation at Jefferies’ 2024 Global Healthcare Conference
Mirion (
NYSEMIR) announced today that its management team’s presentation at Jefferies’ 2024 Global Healthcare Conference will now begin at 3:30 PM ET on Thursday, June 6, 2024.
Mirion Announces Completion of Redemption of its Outstanding Public Warrants
Mirion ("we" or the "Company") (
NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it completed the redemption of its outstanding publicly traded warrants (the “Public Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”), that remained outstanding at 5:00 pm New York City time on Monday, May 20, 2024 (the “Redemption Date”), for a redemption price of $0.10 per Public Warrant (the “Redemption Price”).
Mirion to Present at Jefferies’ 2024 Global Healthcare Conference
Mirion (
NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Jefferies’ 2024 Global Healthcare Conference in New York, NY. The presentation will begin at 4:00 PM ET on Thursday, June 6, 2024.
Mirion Reminds Investors of Redemption of Public Warrants
Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, previously announced on April 18, 2024, that it will redeem all of its publicly traded warrants (the “Public Warrants”) to purchase shares of Class A common stock, par value $0.0001 per share (the “Common Stock”), that remain outstanding at 5:00 p.m. New York City time on Monday, May 20, 2024 (the “Redemption Date”), for a redemption price of $0.10 per Public Warrant (the “Redemption Price”).
Mirion Announces First Quarter 2024 Financial Results and Reaffirms Full Year Guidance
Mirion (“we” or the “company”) (
NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the first quarter ended March 31, 2024.
Mirion Announces Redemption of Public Warrants
Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it will redeem all of its publicly traded warrants to purchase shares of Class A common stock, par value $0.0001 per share (the “Common Stock”), that remain outstanding at 5:00 pm New York City time on Monday, May 20, 2024 (the “Redemption Date”), for a redemption price of $0.10 per warrant (the “Redemption Price”).
Mirion Announces Earnings Release and Conference Call Date for First Quarter 2024
Mirion (
NYSEMIR) announced today that it will release financial results for first quarter 2024 after market close on Tuesday, April 30, 2024. Following the news release, the company will host a conference call the next day, Wednesday, May 1, 2024, at 9:00 am ET to discuss the results.
Mirion to Present at B. Riley Securities’ Radiopharma Day
Mirion (
NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities’ Radiopharma Day in New York, NY. The presentation will begin at 11:30 AM ET on Friday, March 1, 2024.
Mirion to Participate in SHARE Series Fireside Chat on Monday, February 26, 2024
Mirion (
NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, will participate in a SHARE Series fireside chat moderated by Wolfe Research Analyst, Nigel Coe. The event will begin at 9:00 AM ET on Monday, February 26, 2024 and will feature an online portal for investors to submit questions to ask during the event.
Mirion Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Guidance
Mirion ("we" or the "company") (
NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the fourth quarter and full year ended December 31, 2023. Related materials will be available online at ir.mirion.com.
Mirion to Present at Citi’s 2024 Global Industrial Tech and Mobility Conference
Mirion (
NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2024 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation will begin at 1:50 PM ET on Wednesday, February 21, 2024.
Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2023
Mirion (
NYSEMIR) announced today that it will release financial results for the fourth quarter and full year 2023 after market close on Tuesday, February 13, 2024. Following the news release, the company will host a conference call the next day, Wednesday, February 14, 2024, at 10:00 am ET to discuss the results.
